B. Riley Financial Varied
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Cassava Sciences Inc (NQ: SAVA )

26.79 +3.30 (+14.05%)
Streaming Delayed Price Updated: 2:53 PM EDT, Aug 2, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 5,271,852
Open 23.00
Bid (Size) 26.73 (1)
Ask (Size) 26.84 (4)
Prev. Close 23.49
Today's Range 20.50 - 28.65
52wk Range 8.790 - 32.10
Shares Outstanding 41,969,994
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
(SAVA) - Analyzing Cassava Sciences's Short Interest
Via Benzinga
Get Your Money Out of These 3 Healthcare Stocks ASAP
Many companies in the healthcare sector have great outlooks but these healthcare stocks to sell are facing very tough challenges 
Via InvestorPlace

Performance

YTD
+19.49%
+19.49%
1 Month
+127.23%
+127.23%
3 Month
+21.44%
+21.44%
6 Month
+12.37%
+12.37%
1 Year
+27.69%
+27.69%

More News

Read More
8 Best-Performing Small Caps In July: Find Out Which Stock Jumped 803%
Via Benzinga
Cassava Sciences to Hold Conference Call to Discuss Recent Developments and Provide a Company Update on Thursday, August 8, 2024 at 8:30 am ET
From Cassava Sciences, Inc.
Via GlobeNewswire
What's Going On With Cassava Sciences Shares Today?
Via Benzinga
Here's How Much $1000 Invested In Cassava Sciences 5 Years Ago Would Be Worth Today
Via Benzinga
Match Group Posts Upbeat Sales, Joins Modine Manufacturing, Scotts Miracle-Gro, NVIDIA And Other Big Stocks Moving Higher On Wednesday
Via Benzinga
SmartRent (SMRT) Stock Plunges 21% as CEO Steps Down
Via InvestorPlace
Microsoft Office Outage: Microsoft Investigates Applications, Services Issue
Via InvestorPlace
SAVA Stock: Cassava Sciences Extends Simufilam Trials as Much as 36 Months
Via InvestorPlace
Cassava Sciences Announces Expansion of Open-Label Extension Trials
From Cassava Sciences, Inc.
Via GlobeNewswire
Get Your Money Out of These 3 Biotech Stocks Before the End of July
Via InvestorPlace
Nasdaq Up Triple Digits Amid Tech Resurgence
Via Talk Markets
Topics Stocks
Exposures US Equities
Cassava Sciences Advances Alzheimer's Drug Through High-Stakes Phase 3 Trials
Via Benzinga
Why CrowdStrike Shares Are Trading Lower By Around 13%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
Why Is MIRA Pharmaceuticals (MIRA) Stock Up 318% Today?
Via InvestorPlace
RDDT Stock Alert: Reddit Nabs New Deals with NFL, NBA
Via InvestorPlace
SAVA Stock Alert: Cassava Sciences Pops on Late-Stage Trial Update
Via InvestorPlace
IQVIA Posts Upbeat Earnings, Joins Terex, Reddit And Other Big Stocks Moving Higher On Monday
Via Benzinga
Why Cassava Sciences Stock Is Skyrocketing Today
Via The Motley Fool
Dow Jumps 200 Points; Synchrony Financial Posts Upbeat Earnings
Via Benzinga
Topics Stocks
Exposures US Equities
Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials
Via Benzinga
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
SOUN Stock: Sports Bar Chain Rolls Out Voice Tech From SoundHound AI
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
SAVA Stock Plunges as Cassava Sciences CEO Steps Down. What to Know.
Via InvestorPlace
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
B. Riley Financial's diverse suite of services goes beyond traditional financial service offerings. By leveraging cross-platform expertise and assets, B. Riley Financial companies are uniquely positioned to provide full service, collaborative solutions to our clients at every stage of the business life cycle and in all market conditions.

B. Riley refers to B. Riley Financial, Inc. and/or one or more of its subsidiaries or affiliates. Click here for further details.